Gene-Edited Pigs Gain FDA Approval

The Food and Drug Administration has approved gene-editing technology to make pigs resistant to Porcine Reproductive and Respiratory Syndrome. The swine genetics firm, PIC, is the first company to receive this approval. PRRS has a $1.2 billion impact on the U.S. swine industry. The first PRRS-resistant pigs will be available commercially in 2026.